1. Risk of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

   • Zhigui Zheng
   • Dongyuan He
   • Xinxin Jiang

   Systematic Review 03 April 2023 Pages: 209 - 225

   

2. Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?

   • Aurora Gonzalez-Fierro
   • Adriana Romo-Pérez
   • Alfonso Duenas-Gonzalez

   Review Article Open access 08 March 2023 Pages: 227 - 239

3. Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers

   • Xiangyou Yu
   • Yan Hao
   • Fuqiang Liu

   Original Research Article 16 March 2023 Pages: 241 - 250

   

4. A Cost-effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China

   • Yanqing Jiang
   • Ruizhe Liu
   • Jianxin Pang

   Original Research Article 21 March 2023 Pages: 251 - 263

   

5. Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System

   • Zhe Wang
   • Yake Lou
   • Yuehui Wang

   Original Research Article 28 March 2023 Pages: 265 - 275

   

6. Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial

   • Geert D’Haens
   • Walter Reinisch
   • Shomron Ben-Horin

   Original Research Article Open access 01 April 2023 Pages: 277 - 288

   

7. Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021

   • Young Eun Shin
   • Arun Kumar
   • Jeff Jianfei Guo

   Original Research Article 01 April 2023 Pages: 289 - 298

   

8. Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study

   • Axel De Greef
   • Pierre-Dominique Ghislain
   • Marie Baeck

   Short Communication Open access 03 April 2023 Pages: 299 - 306

   

9. Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria

   • Carolin Prinz
   • Frank Streit
   • Lars-Olav Harnisch

   Short Communication 05 April 2023 Pages: 307 - 314